New development of breast cancer histological evaluation related to determination of therapeutic option for the patients

被引：0

作者：

Kentaro Tamaki ^{[1
,2
]}

Hironobu Sasano ^{[2
]}

机构：

[1] Department of Breast Surgery, Nahanishi clinic, Okinawa, Japan

[2] Department of Pathology, Tohoku University Hospital, - Seiryo-machi, Aoba-ku Sendai, Miyagi -, Japan

来源：

中华乳腺病杂志(电子版) | 2011年 / 5卷 / 06期

关键词：

breast neoplasms; histological evaluation; therapy;

D O I：

暂无

中图分类号：

R737.9 [乳腺肿瘤];

学科分类号：

100214 ;

摘要：

<正>Breast cancer is a heterogenous disease with molecular alterations,cellular composition, and clinical outcome. The more we know about the tumor characteristics underlying the heterogeneity of the disease, the greater the opportunity to refine treatment options. Great emphasis has been placed upon

引用

页码：721 / 728

页数：8

共 5 条

[1] Immunohistochemical assessment of hormone receptor status using a new scoring system (J-Score) in breast cancer. [J].

Kurosumi M. .

Breast Cancer, 2007, 14 (2) :189-193

[2] New trends of immunohistochemistry for making differential diagnosis of breast lesions [J].

Moriya, Takuya ;

Kasajima, Atsuko ;

Ishida, Kazuyuki ;

Kariya, Yoshiyuki ;

Akahira, Jun-ichi ;

Endoh, Mareyuki ;

Watanabe, Mika ;

Sasano, Hironobu .

MEDICAL MOLECULAR MORPHOLOGY, 2006, 39 (01) :8-13

[3]

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. Harvey JM, Clark GM, Osborne CK, et al. Journal of Clinical Oncology . 1999

[4]

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Hammond MEH,Hayes DF,Dowsett M,et al. Journal of Clinical Oncology . 2010

[5]

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. Viale, G,A. Giobbie-Hurder,M.M. Reganet al. Journal of Clinical Oncology . 2008

← 1 →